Results
|
|
7621.
|
|
|
|
7622.
|
|
|
|
7623.
|
|
|
|
7624.
|
|
|
|
7625.
|
|
|
|
7626.
|
|
|
|
7627.
|
|
|
|
7628.
|
|
|
|
7629.
|
|
|
|
7630.
|
|
|
|
7631.
|
|
|
|
7632.
|
Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma. [electronic resource] by
- Usmani, S Z
- Cavenagh, J D
- Belch, A R
- Hulin, C
- Basu, S
- White, D
- Nooka, A
- Ervin-Haynes, A
- Yiu, W
- Nagarwala, Y
- Berger, A
- Pelligra, C G
- Guo, S
- Binder, G
- Gibson, C J
- Facon, T
Producer: 20161216
In:
Journal of medical economics vol. 19
Availability: No items available.
|
|
|
7633.
|
|
|
|
7634.
|
|
|
|
7635.
|
|
|
|
7636.
|
|
|
|
7637.
|
|
|
|
7638.
|
|
|
|
7639.
|
|
|
|
7640.
|
|